Highly Soluble Glimepiride and Irbesartan Co-amorphous Formulation with Potential Application in Combination Therapy
Crossref DOI link: https://doi.org/10.1208/s12249-019-1359-2
Published Online: 2019-03-18
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cruz-Angeles, Jorge
Videa, Marcelo
Martínez, Luz María http://orcid.org/0000-0002-5449-1621
Text and Data Mining valid from 2019-03-18
Article History
Received: 18 December 2018
Accepted: 3 March 2019
First Online: 18 March 2019